Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS

HIV Medicine

Volumn 10, Issue 9, 2009, Pages 564-572

  Gutierrez, E B ^a   Gomes, V ^a   Picone, C M ^a   Suga, H ^a   Atomiya, A N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; HIV; Isoniazid therapy; Tuberculin test; Tuberculosis

Indexed keywords

ISONIAZID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; BRAZIL; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SEX DISTRIBUTION; SEXUAL BEHAVIOR; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 70350074784     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00730.x     Document Type: Article

References (29)

1. 2008, http://www.stoptb.org/resource_center/assets/documents/WHO_2008_global_T B_report.pdf, World Health Organization, Global tuberculosis control 2008. Surveillance, planning, financing [Online]. Available at, (accessed 22 November 2008)
2. Toossi Z, Wu M, Islam N, Teixeira-Johnson L, Hejal R, Aung H. Transactivation of human immunodeficiency virus-1 in T-cells by Mycobacterium tuberculosis-infected mononuclear phagocytes. J Lab Clin Med 2004, 144:108-115.
3. 2008, http://www.who.int/hiv/pub/meetingreports/WHO_3Is_meeting_report.pdf, World Health Organization, WHO three 'I's meeting: Intensified Case Finding (ICF), Isoniazid Preventive Treatment (IPT) and TB Infection Control (IC) for People Living With HIV. Report of a Joint World Health Organization HIV/AIDS and TB Department Meeting, World Health Organization. HIV Department. Geneva, Switzerland, 2-4 April 2008 [Online]. Available at, (accessed 22 November 2008)
4. http://www.aids.gov.br/data/documents/storedDocuments/%7BB8EF5DAF-23AE-4 891-AD36-1903553A3174%7D/%7B762E0EBF-A859-4779-8A92-704EB1F3B290%7D/cons ensoAdulto005c_2008montado.pdf, Brasil, Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e AIDS. 2008. Recomendações para terapia anti-retroviral em adultos infectados pelo HIV: 2008/Ministério da Saúde, Secretaria de Vigilância em Saúde, Programa Nacional de DST e Aids. 7a Ed. - Brasília, Ministério da Saúde 244p.: il. - (Série Manuais n° 2). Available at, (accessed 20 February 2009)
5. 2007, http://www.ibge.gov.br/home/estatistica/populacao/contagem2007/contagem_ final/tabela1_1_20.pdf, IBGE, Instituto Brasileiro de Geografia e Estatística. Tabela 1.1.20 - População recenseada e estimada, segundo os municípios - São Paulo. Available at, (accessed 10 February 2009)
6. http://www.aids.gov.br/data/documents/storedDocuments/%7BB8EF5DAF-23AE-4 891-AD36-1903553A3174%7D/%7B762E0EBF-A859-4779-8A92-704EB1F3B290%7D/cons ensoAdulto005c_2008montado.pdf, Brasil, Ministério da Saúde. Secretaria de Vigilância em Saúde. 2003. Programa Nacional de DST e AIDS. Critérios de definição de casos de AIDS em adultos e crianças./Ministério da Saúde, Secretaria de Vigilância em Saúde, Programa Nacional de DST e Aids. Brasília: Ministério da Saúde, 2003. 56p. il. - (Série Manuais n.° 60). Available at, (accessed 14 February 2009)
7. Barbosa RM, Koyama MAH and. Sexual behavior and practices among men and women, Brazil 1998 and 2005. Rev Saúde Pública 2008, 42:21-33. grupo de estudos em população, sexualidade e AIDS
8. Braga P, Cardoso MRA, Segurado AC. Gender differences in survival in an HIV/AIDS cohort in São Paulo, Brazil. AIDS Patient Care STDS 2007, 21:321-328.
9. http://portal.saude.gov.br/portal/arquivos/pdf/tuberculose_2006.pdf, Brasil, Ministério da Saúde. 2006. Tuberculose - Distribuição de casos confirmados, por Unidade Federada, Brasil, 1980-2005. Available at, (accessed 10 February 2009)
10. Jamal LF, Moherdaui F. Tuberculose e infecção pelo HIV no Brasil. Rev Saúde Pública 2007, 42((Suppl. 1)):104-110.
11. Guimarães MDC. Temporal trends in AIDS-associated opportunistic infections in Brazil, 1980-1999. Rep Public Health 2000, 165((Suppl. 1)):21-36.
12. Saraceni V, King BS, Cavalcante SC. Tuberculosis as a primary cause of death among AIDS cases in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2008, 12:769-772.
13. Fisk TL, Hon HM, Lennox JL, Fordham von Reyn C, Horsburgh CR. Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy. AIDS 2003, 17:1102-1104.
14. Gustafson P, Lisse I, Gomes V. Risk factors for positive tuberculin skin test in Guinea-Bissau. Epidemiology 2007, 18:340-347.
15. French AL, Evans CT, Anastos K. Incidence of tuberculin skin test conversion among HIV-infected and -uninfected women. J Acquir Immune Defic Syndr 2006, 42:592-596.
16. Menzies D. What does tuberculin reactivity after Bacille Calmétte-Guerin vaccination tells us?. CID 2000, 31:S71-S74.
17. Wang L, Tuner MO, Elkwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette-Guérin vaccination on tuberculin skin test measurements. Thorax 2002, 57:804-809.
18. Havlir DV, Getahun H, Sannet I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 2008, 300:423-430.
19. Churchyard GJ, Scano F, Grant AD, Chaisson RE. Tuberculosis preventive therapy in the era of HIV infection. J Infect Dis 2007, 196((Suppl. 1)):S52-S62.
20. Lee LM, Lobato MN, Buskin SE, Morse A, Costa S. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States. Int J Tuberc Lung Dis 2006, 10:209-214.
21. Elzi L, Schlegel M, Weber R. Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007, 44:94-102.
22. Kaplan J, Parham DL, Soto-Torres L. Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States. J Acquir Immune Defic Syndr 1999, 21:228-235.
23. Nelson K. Tuberculin testing to detect latent tuberculosis in developing countries. Epidemiology 2007, 18:348-349.
24. DeRiemer K, Daley CL, Reingold AL. Preventing tuberculosis among HIV-infected persons. Prev Med 1999, 28:437-444.
25. Dheda K, Lalvani A, Miller RF. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005, 19:2038-2041.
26. Vincenti D, Carrara S, Butera O. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis. Clin Exp Immunol 2007, 150:91-98.
27. Nagai H, Kawabe Y, Ariga H. Usefulness of a whole blood interferon gamma assay (QuantiFERON-TB-2G) for detecting tuberculosis infection in HIV-infected persons. Kekkaku 2007, 82:635-640. (in Japanese)
28. Rangaka MX, Wilkinson KA, Seldon R. Effect of HIV-1 infection on T-cell based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007, 175:514-520.
29. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf, Panel on Antiretroviral Guidelines for Adults and Adolescents, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 3 November 2008; pp. 1-139. [Online]. Available at, (accessed 14 February 2009)